Crossmark

Re: Yildiz BP, Bayraktaroglu M, Gunen H. Bronchodilator efficacy of tiotropium/formoterol (18/12 μg once daily <i>via</i> a Discair inhaler), tiotropium alone (18 μg by Handihaler) or combined with formoterol (12 μg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD. Curr Med Res Opin. 2019;35(12):2187–2196

Crossref DOI link: https://doi.org/10.1080/03007995.2020.1754184

Published Online: 2020-04-29

Published Print: 2020-06-02

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Kalemci, Serdar https://orcid.org/0000-0002-5246-972X
Sarihan, Aydin https://orcid.org/0000-0002-7489-0734
Kargı, Ahmet Bülent

Şimşek, Abdullah https://orcid.org/0000-0003-0588-3888
Zeybek, Arife https://orcid.org/0000-0003-3656-9947
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=icmo20

Publication History

Received: 2019-12-03

Revised: 2020-02-14

Accepted: 2020-04-04

Published: 2020-04-29

Document is current

Any future updates will be listed below